Calreticulin: Endoplasmic reticulum Ca 2+ gatekeeper
Journal of Cellular and Molecular Medicine · 2024-03 · 28 (5)
DOI: 10.1111/jcmm.17839 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 09.07.2023. Verfasst von Marek Michalak. Beteiligte Einrichtung: Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Calreticulin, Endoplasmic Reticulum, Calcium, Calcium Signaling. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canada Foundation for Innovation, Multiple Sclerosis Society.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) luminal Ca 2+ is vital for the function of the ER and regulates many cellular processes. Calreticulin is a highly conserved, ER‐resident Ca 2+ binding protein and lectin‐like chaperone. Over four decades of studying calreticulin demonstrate that this protein plays a crucial role in maintaining Ca 2+ supply under different physiological conditions, in managing access to Ca 2+ and how Ca 2+ is used depending on the environmental events and in making sure that Ca 2+ is not misused. Calreticulin plays a role of ER luminal Ca 2+ sensor to manage Ca 2+ ‐dependent ER luminal events including maintaining interaction with its partners, Ca 2+ handling molecules, substrates and stress sensors. The protein is strategically positioned in the lumen of the ER from where the protein manages access to and distribution of Ca 2+ for many cellular Ca 2+ ‐signalling events. The importance of calreticulin Ca 2+ pool extends beyond the ER and includes influence of cellular processes involved in many aspects of cellular pathophysiology. Abnormal handling of the ER Ca 2+ contributes to many pathologies from heart failure to neurodegeneration and metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Marek Michalak
Förderung
- CIHR
- Canada Foundation for Innovation
- Multiple Sclerosis Society
- Natural Sciences and Engineering Research Council of Canada
- SynAD
- Kenneth and Sheelagh McCourt Family
- University Hospital Foundation
- Women and Children's Health Research Institute
Zitieren
APA
Michalak, M. (2024). Calreticulin: Endoplasmic reticulum Ca 2+ gatekeeper. Journal of Cellular and Molecular Medicine, 28(5). https://doi.org/10.1111/jcmm.17839
Vancouver
Michalak M. Calreticulin: Endoplasmic reticulum Ca 2+ gatekeeper. Journal of Cellular and Molecular Medicine. 2024;28(5). doi:10.1111/jcmm.17839
BibTeX
@article{Michalak2024,
author = {Michalak, Marek},
title = {Calreticulin: Endoplasmic reticulum Ca 2+ gatekeeper},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {5},
doi = {10.1111/jcmm.17839}
}
EUVIMED